Background
Methods
Study population
Groups | NC group (n = 73) | CAE-A (n = 60) (age ≤ 50 years) | CAE-B (n = 83) (50 years<age ≤ 70 years) | CAE-C (n = 74) (age > 70 years) | Total CAE (A + B + C, n = 217) | p-value | CAE-A vs CAE-B | CAE-B vs CAE-C | CAE-A vs CAE-C |
---|---|---|---|---|---|---|---|---|---|
Sex (M), n (%) | 42 (57.5) | 39 (65.0) | 57 (68.7) | 50 (67.6) | 146 (67.3) | 0.2794 | |||
Diabetes mellitus, n (%) | 13 (17.8) | 11 (18.3) | 18 (21.6) | 18 (24.3) | 47 (21.7) | 0.1712 | |||
Hypertension, n (%) | 23 (31.5) | 19 (31.7) | 28 (33.7) | 27 (36.5) | 74 (34.1) | 0.2142 | |||
Waist circumference (cm) | 90.3 ± 14.8 | 91.6 ± 12.7 | 92.7 ± 16.1 | 93.8 ± 19.1 | 92.8 ± 16.2 | 0.5277 | |||
Creatinine (mg/dL) | 70.34 ± 11.6 | 67.6 ± 12.7 | 77.8 ± 13.2 | 87.8 ± 14.8 | 78.48 ± 12.5 | 0.2560 | |||
Smoking index | 119.2 ± 15.5 | 110.3 ± 10.5 | 135.5 ± 15.6 | 130.2 ± 15.1 | 126.7 ± 17.8 | 0.2391 | |||
Total cholesterol (mmol/L) | 4.89 ± 1.04 | 5.59 ± 1.21* | 5.39 ± 1.18 | 4.95 ± 1.07 | 5.30 ± 1.16* | 0.0452 | 0.321 | 0.252 | 0.175 |
Low-density lipoprotein-C (mmol/L) | 2.89 ± 0.36 | 3.92 ± 0.54* | 3.74 ± 0.51* | 3.73 ± 0.49* | 3.79 ± 0.52* | 0.0237 | 0.434 | 0.523 | 0.259 |
High-density lipoprotein-C (mmol/L) | 1.08 ± 0.12 | 1.22 ± 0.27 | 1.15 ± 0.19 | 1.13 ± 0.15 | 1.16 ± 0.16 | 0.9161 | |||
Triglycerides (mmol/L) | 1.56 ± 0.19 | 1.69 ± 0.19 | 1.89 ± 0.21 | 1.75 ± 0.18 | 1.78 ± 0.15 | 0.8493 | |||
High-sensitivity CRP (mg/L) | 16.9 ± 3.82 | 32.3 ± 5.51* | 26.1 ± 4.23* | 22.5 ± 4.82* | 25.6 ± 4.65* | 0.0213 | 0.230 | 0.198 | 0.048* |
Glycated hemoglobin (%) | 5.89 ± 1.12 | 5.90 ± 1.07 | 6.50 ± 1.12 | 6.89 ± 1.25 | 6.46 ± 1.21 | 0.1421 | |||
Ejection fraction (%) | 56.3 ± 12.58 | 59.4 ± 9.14 | 55.5 ± 9.23 | 50.3 ± 8.47 | 54.8 ± 8.53 | 0.3432 | |||
Hemoglobin (g/L) | 125.5 ± 26.5 | 131.1 ± 28.6 | 125.1 ± 26.3 | 119.1 ± 29.8 | 123.8 ± 28.1 | 0.6535 | |||
Red blood cell distribution width (%) | 36.8 ± 5.26 | 36.7 ± 5.95 | 38.7 ± 4.94 | 36.4 ± 4.68 | 37.4 ± 5.59 | 0.8601 | |||
Mean platelet volume (fL) | 10.5 ± 1.26 | 10.7 ± 1.05 | 11.2 ± 1.35 | 10.5 ± 1.91 | 10.8 ± 1.45 | 0.2503 | |||
WBC (109/L) | 6.25 ± 2.56 | 8.85 ± 2.21 | 8.35 ± 2.06 | 8.25 ± 2.36 | 8.38 ± 2.30 | 0.0763 | |||
Neutrophils (109/L) | 4.12 ± 1.69 | 6.12 ± 1.58 | 5.76 ± 1.49 | 5.66 ± 1.52 | 5.89 ± 1.60 | 0.0752 | |||
Lymphocytes (109/L) | 0.50 ± 0.22 | 0.65 ± 0.25 | 0.68 ± 0.23 | 0.72 ± 0.20 | 0.70 ± 0.23 | 0.3854 | |||
Neutrophils/Lymphocytes ratio | 8.18 ± 5.36 | 9.42 ± 6.89 | 8.48 ± 6.56 | 7.87 ± 6.36 | 8.41 ± 6.60 | 0.1025 | |||
Interleukin-6 (pg/dL) | 4.1 ± 0.6 | 12.3 ± 1.5* | 10.9 ± 1.3* | 8.9 ± 1.1* | 10.6 ± 1.3* | 0.001 | 0.120 | 0.095 | 0.025* |
Measurement of related indicator characteristics
Coronary angiography
Statistical analysis
Results
OR | 95% CI | p-value | |
---|---|---|---|
Hypertension | 1.364 | 0.932–1.648 | 0.248 |
Diabetes mellitus | 1.407 | 0.802–2.053 | 0.198 |
Waist circumference | 1.448 | 0.967–1.938 | 0.124 |
Total Cholesterol | 1.462 | 0.970–1.965 | 0.112 |
LDL-C | 1.492 | 0.986–2.091 | 0.099 |
Smoking | 1.119 | 0.932–1.422 | 0.176 |
TGs | 1.238 | 0.836–1.865 | 0.236 |
WBC | 1.690 | 0.990–1.785 | 0.061 |
hs-CRP | 1.782 | 1.124–2.014 | 0.021* |
Interleukin-6 | 1.584 | 1.112–1.986 | 0.030* |
Treatments | Group NC (n = 73) | CAE-A (n = 60) (age ≤ 50 years) | CAE-B (n = 83) (50 years<age ≤ 70 years) | CAE-C (n = 74) (age > 70 years) | Total CAE (A + B + C, n = 217) | p-value |
---|---|---|---|---|---|---|
ACEI/ARB | 18 | 16 | 27 | 28 | 71 | 0.895 |
β-receptor blocker | 21 | 25 | 36 | 28 | 89 | 0.424 |
Rosuvastatin | 73 | 60 | 83 | 74 | 217 | 0.945 |
Calcium-channel blocker | 16 | 18 | 15 | 17 | 50 | 0.310 |
Diuretics | 14 | 15 | 13 | 16 | 44 | 0.769 |
Aspirin | 35 | 42 | 56 | 50 | 148 | 0.424 |
Groups | CAE-A (n = 60) (age ≤ 50) | CAE-B (n = 83) (50 < age ≤ 70) | CAE-C (n = 74) (age > 70) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pretreatment | Posttreatment | Delta | p-value | Pretreatment | Posttreatment | Delta | p-value | Pretreatment | Posttreatment | Delta | p-value | |
hs-CRP (mg/L) | 32.3 ± 5.51 | 17.5 ± 2.38 * | 15.1 ± 3.3 | 0.0001 | 26.1 ± 4.23 | 18.8 ± 2.74 * | 9.4 ± 2.86 | 0.023 | 22.5 ± 4.82 | 19.8 ± 2.98 | 4.5 ± 3.12 | 0.310 |
IL-6 (pg/dL) | 12.3 ± 1.5 | 6.4 ± 1.7* | 5.9 ± 1.6 | 0.021 | 10.9 ± 1.3 | 7.5 ± 2.0* | 3.0 ± 1.5 | 0.043 | 8.9 ± 1.1 | 7.6 ± 2.3 | 1.9 ± 1.5 | 0.519 |